Predictors of Contralateral Prophylactic Mastectomy in Genetically High Risk Newly Diagnosed Breast Cancer Patients

PURPOSE: Recent trends indicate increased use of contralateral prophylactic mastectomy (CPM) among newly diagnosed breast cancer patients, particularly those who test positive for a pathogenic variant in the BRCA1/2 genes. However, the rate of CPM among patients who test negative or choose not to be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Principais autores: Tynan, Mara, Peshkin, Beth N., Isaacs, Claudine, Willey, Shawna, Valdimarsdottir, Heiddis B., Nusbaum, Rachel, Hooker, Gillian, O’Neill, Suzanne C., Jandorf, Lina, Kelly, Scott P., Heinzmann, Jessica, Kelleher, Sarah, Poggi, Elizabeth, Schwartz, Marc D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7035174/
https://ncbi.nlm.nih.gov/pubmed/31894446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05515-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados